Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

• Hoofdauteurs: Yadan Liu (Auteur), Bin Liang (Auteur), Yan Liu (Auteur), Guoqing Wei (Auteur), Wenjun Wu (Auteur), Luxin Yang (Auteur), Li Yang (Auteur), He Huang (Auteur), Jue Xie (Auteur), Yongxian Hu (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2021-07-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Chimeric antigen receptor T cell (CAR-T) therapy is successful in improving treatment outcomes for relapsed/refractory acute lymphoblastic leukemia (R/R ALL). However, toxicities associated with CAR-T therapy are being increasingly identified. Pancytopenia is one of the most common compl...